CORMEDIX INC. Basic Shares Outstanding (Weighted Average)
CORMEDIX INC. (CRMD) reported Basic Shares Outstanding (Weighted Average) of 78.44 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- CORMEDIX INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 78.44M shares, a 15.48% increase year-over-year.
- CORMEDIX INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 79.51M shares, a 21.86% increase year-over-year.
- CORMEDIX INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -208.93M shares.
- CORMEDIX INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 75.93M shares, a 29.08% increase year-over-year.
- CORMEDIX INC. weighted average number of shares outstanding, basic for fiscal 2025 was 72.03K shares, a 22.36% increase from fiscal 2024.
- CORMEDIX INC. weighted average number of shares outstanding, basic for fiscal 2024 was 58.87K shares, a 99.88% decline from fiscal 2023.
- CORMEDIX INC. weighted average number of shares outstanding, basic for fiscal 2023 was 50.90M shares, a 26.39% increase from fiscal 2022.
- CORMEDIX INC. weighted average number of shares outstanding, basic for fiscal 2022 was 40.27M shares, a 6.92% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 78.44M shares 10-Q · filed 2026-08-13 | 78.95M shares 10-Q · filed 2026-08-13 | -16.99M shares derived: average of 3 quarters · filed 2026-08-13 | 6.24M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 79.51M shares 10-Q · filed 2026-05-14 | -64.71M shares derived: average of 2 quarters · filed 2026-05-14 | -17.83M shares derived: average of 3 quarters · filed 2026-05-14 | 3.61M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -208.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -66.50M shares derived: average of 2 quarters · filed 2026-03-05 | -21.69M shares derived: average of 3 quarters · filed 2026-08-13 | 72.03K shares 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | 75.93M shares 10-Q · filed 2025-11-12 | 71.93M shares derived: average of 2 quarters · filed 2026-08-13 | 69.74M shares 10-Q · filed 2025-11-12 | 8.84M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 67.93M shares 10-Q · filed 2026-08-13 | 67.93M shares 10-Q · filed 2025-08-07 | 66.59M shares 10-Q · filed 2026-08-13 | 66.59M shares 10-Q · filed 2025-08-07 | -13.52M shares derived: average of 3 quarters · filed 2026-08-13 | 4.57M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | 65.24M shares 10-Q · filed 2026-05-14 | 65.24M shares 10-Q · filed 2025-05-06 | -54.24M shares derived: average of 2 quarters · filed 2026-05-14 | -16.55M shares derived: average of 3 quarters · filed 2026-05-14 | 1.99M shares derived: average of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -173.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -57.45M shares derived: average of 2 quarters · filed 2026-03-05 | -19.09M shares derived: average of 3 quarters · filed 2026-03-05 | 58.87K shares 10-K · filed 2026-03-05 | 58.87M shares 10-K · filed 2025-03-25 | |||
| 2024-09-30 | 58.83M shares 10-Q · filed 2025-11-12 | 58.22M shares derived: average of 2 quarters · filed 2025-11-12 | 57.99M shares 10-Q · filed 2025-11-12 | 57.85M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 57.62M shares 10-Q · filed 2025-08-07 | 57.56M shares 10-Q · filed 2025-08-07 | 57.53M shares derived: average of 3 quarters · filed 2025-08-07 | 57.29M shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 57.50M shares 10-Q · filed 2025-05-06 | 57.48M shares derived: average of 2 quarters · filed 2025-05-06 | 57.17M shares derived: average of 3 quarters · filed 2025-05-06 | 54.22M shares derived: average of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | 57.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 57.01M shares derived: average of 2 quarters · filed 2025-03-25 | 53.13M shares derived: average of 3 quarters · filed 2025-03-25 | 50.90M shares 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | 56.55M shares 10-Q · filed 2024-10-30 | 50.96M shares derived: average of 2 quarters · filed 2024-10-30 | 48.72M shares 10-Q · filed 2024-10-30 | 46.97M shares derived: average of 4 quarters · filed 2024-10-30 | ||||
| 2023-06-30 | 45.37M shares 10-Q · filed 2024-08-14 | 44.73M shares 10-Q · filed 2024-08-14 | 43.78M shares derived: average of 3 quarters · filed 2024-08-14 | 43.13M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 44.09M shares 10-Q · filed 2024-05-09 | 42.98M shares derived: average of 2 quarters · filed 2024-05-09 | 42.38M shares derived: average of 3 quarters · filed 2024-05-09 | 41.73M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 41.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 41.53M shares derived: average of 2 quarters · filed 2024-03-12 | 40.94M shares derived: average of 3 quarters · filed 2024-03-12 | 40.27M shares 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | 41.18M shares 10-Q · filed 2023-11-14 | 40.47M shares derived: average of 2 quarters · filed 2023-11-14 | 39.74M shares 10-Q · filed 2023-11-14 | 39.33M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 39.76M shares 10-Q · filed 2023-08-08 | 39.01M shares 10-Q · filed 2023-08-08 | 38.71M shares derived: average of 3 quarters · filed 2023-08-08 | 38.56M shares derived: average of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | 38.25M shares 10-Q · filed 2023-05-15 | 38.18M shares derived: average of 2 quarters · filed 2023-05-15 | 38.16M shares derived: average of 3 quarters · filed 2023-05-15 | 38.14M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 38.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 38.12M shares derived: average of 2 quarters · filed 2023-03-30 | 38.11M shares derived: average of 3 quarters · filed 2023-03-30 | 37.67M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 38.11M shares 10-Q · filed 2022-11-10 | 38.10M shares derived: average of 2 quarters · filed 2022-11-10 | 37.52M shares 10-Q · filed 2022-11-10 | 7.72 shares 10-Q · filed 2021-11-09 | ||||
| 2021-06-30 | 38.08M shares 10-Q · filed 2022-08-11 | 37.21M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 36.33M shares 10-Q · filed 2022-05-12 | |||||||
| 2015-06-30 | 31.62M shares 10-Q · filed 2015-08-06 | 27.79M shares 10-Q · filed 2015-08-06 | ||||||
| 2014-06-30 | 21.99M shares 10-Q · filed 2015-08-06 | 20.64M shares 10-Q · filed 2015-08-06 | ||||||
| 2013-06-30 | 13.05M shares 10-Q · filed 2014-08-14 | 12.33M shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |